Research gives new insight into coeliac disease

October 11, 2012

For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

Published today in Immunity, the discovery was led by Dr Hugh Reid and Professor Jamie Rossjohn of Monash University, Professor Frits Koning of the University of Leiden and Dr Bob Anderson of ImmusanT Inc, based in the US.

An increasingly diagnosed , coeliac disease affects the of the . When a person with coeliac disease consumes gluten, their immune system triggers T-cells to fight the offending proteins, damaging the small intestine and inhibiting the absorption of important nutrients into the body. There are currently no treatments available apart from a diet completely free of gluten.

The researchers used the Australian Synchrotron to visually determine how T-cells of the immune system interact with gluten, a protein found in wheat, rye and barley, which causes coeliac disease, The discovery will boost attempts to produce a treatment allowing sufferers to resume a normal diet.

About half the population is genetically susceptible to coeliac disease because they carry the immune response genes HLA-DQ2 or HLA-DQ8. At least one in 20 people who carry HLA-DQ2 and about one in 150 who have HLA-DQ8 develop coeliac disease, but people with other versions of the HLA-DQ genes are protected.

This has led researchers to question how the senses gluten.

Dr. Reid, a senior research fellow at Monash University, said the discovery was an important breakthrough for coeliac disease and autoimmune disease.

"This is the first time that the intricacies of the interaction between gluten and two proteins that initiate immune responses have been visualised at a sub-molecular level," Dr. Reid said.

This insight into a central event in coeliac disease will assist ImmusanT to develop a blood test and a therapeutic vaccine, Nexvax2®, for patients with coeliac disease who carry the gene HLA-DQ2. It is intended to restore immune tolerance to gluten and allow patients to return to again include gluten in their diet.

Future studies will investigate whether T-cell activation by gluten in patients with HLA-DQ2 follows similar principles as observed in this study that focused on HLA DQ8 mediated coeliac disease.

Chief Scientific Officer at ImmusanT, Dr Bob Anderson said the research presented a unique opportunity.

"Because we now know the peptides responsible for coeliac disease, we can interrogate the molecular events leading to a self-destructive ," Dr Anderson said.

Related Stories

Glowing abdomens reveal enzyme activity

August 16, 2011

Professor Jean-Christophe Leroux and his colleagues have developed a method with which they can observe gluten-splitting enzymes in a living organism. This is an important step towards developing effective digestive proteins ...

Recommended for you

How to become a T follicular helper cell

July 30, 2015

Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the ...

Uncovering the secrets of immune system invaders

July 20, 2015

The human immune system is a powerful and wonderful creation. If you cut your skin, your body mobilizes a series of different proteins and cells to heal the cut. If you are infected by a virus or bacteria, your immune system ...

The role of the microbiota in preventing allergies

July 10, 2015

The human body is inhabited by billions of symbiotic bacteria, carrying a diversity that is unique to each individual. The microbiota is involved in many mechanisms, including digestion, vitamin synthesis and host defense. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.